Protection of mice against the lyme disease agent by immunizing with recombinant OspA

Erol Fikrig, Stephen W Barthold, Fred S. Kantor, Richard A. Flavell

Research output: Contribution to journalArticle

333 Citations (Scopus)

Abstract

Lyme borreliosis is a tick-borne illness caused by Borrelia burgdorferi. The gene for outer surface protein A (OspA) from B. burgdorferi strain N40 was cloned into an expression vector and expressed in Escherichia coli. C3H/HeJ mice actively immunized with live transformed E. coli or purified recombinant OspA protein produced antibodies to OspA and were protected from challenge with several strains of B. burgdorferi. Recombinant OspA is a candidate for a vaccine for Lyme borreliosis.

Original languageEnglish (US)
Pages (from-to)553-556
Number of pages4
JournalScience
Volume250
Issue number4980
StatePublished - Oct 26 1990
Externally publishedYes

Fingerprint

Lyme Disease
Borrelia burgdorferi
Escherichia coli
Inbred C3H Mouse
Ticks
Vaccines
OspA protein
Antibodies
Genes
Proteins

ASJC Scopus subject areas

  • General

Cite this

Fikrig, E., Barthold, S. W., Kantor, F. S., & Flavell, R. A. (1990). Protection of mice against the lyme disease agent by immunizing with recombinant OspA. Science, 250(4980), 553-556.

Protection of mice against the lyme disease agent by immunizing with recombinant OspA. / Fikrig, Erol; Barthold, Stephen W; Kantor, Fred S.; Flavell, Richard A.

In: Science, Vol. 250, No. 4980, 26.10.1990, p. 553-556.

Research output: Contribution to journalArticle

Fikrig, E, Barthold, SW, Kantor, FS & Flavell, RA 1990, 'Protection of mice against the lyme disease agent by immunizing with recombinant OspA', Science, vol. 250, no. 4980, pp. 553-556.
Fikrig, Erol ; Barthold, Stephen W ; Kantor, Fred S. ; Flavell, Richard A. / Protection of mice against the lyme disease agent by immunizing with recombinant OspA. In: Science. 1990 ; Vol. 250, No. 4980. pp. 553-556.
@article{83a1059c822e41a1ba524c3f4b18f9c7,
title = "Protection of mice against the lyme disease agent by immunizing with recombinant OspA",
abstract = "Lyme borreliosis is a tick-borne illness caused by Borrelia burgdorferi. The gene for outer surface protein A (OspA) from B. burgdorferi strain N40 was cloned into an expression vector and expressed in Escherichia coli. C3H/HeJ mice actively immunized with live transformed E. coli or purified recombinant OspA protein produced antibodies to OspA and were protected from challenge with several strains of B. burgdorferi. Recombinant OspA is a candidate for a vaccine for Lyme borreliosis.",
author = "Erol Fikrig and Barthold, {Stephen W} and Kantor, {Fred S.} and Flavell, {Richard A.}",
year = "1990",
month = "10",
day = "26",
language = "English (US)",
volume = "250",
pages = "553--556",
journal = "Science",
issn = "0036-8075",
publisher = "American Association for the Advancement of Science",
number = "4980",

}

TY - JOUR

T1 - Protection of mice against the lyme disease agent by immunizing with recombinant OspA

AU - Fikrig, Erol

AU - Barthold, Stephen W

AU - Kantor, Fred S.

AU - Flavell, Richard A.

PY - 1990/10/26

Y1 - 1990/10/26

N2 - Lyme borreliosis is a tick-borne illness caused by Borrelia burgdorferi. The gene for outer surface protein A (OspA) from B. burgdorferi strain N40 was cloned into an expression vector and expressed in Escherichia coli. C3H/HeJ mice actively immunized with live transformed E. coli or purified recombinant OspA protein produced antibodies to OspA and were protected from challenge with several strains of B. burgdorferi. Recombinant OspA is a candidate for a vaccine for Lyme borreliosis.

AB - Lyme borreliosis is a tick-borne illness caused by Borrelia burgdorferi. The gene for outer surface protein A (OspA) from B. burgdorferi strain N40 was cloned into an expression vector and expressed in Escherichia coli. C3H/HeJ mice actively immunized with live transformed E. coli or purified recombinant OspA protein produced antibodies to OspA and were protected from challenge with several strains of B. burgdorferi. Recombinant OspA is a candidate for a vaccine for Lyme borreliosis.

UR - http://www.scopus.com/inward/record.url?scp=0025202254&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0025202254&partnerID=8YFLogxK

M3 - Article

VL - 250

SP - 553

EP - 556

JO - Science

JF - Science

SN - 0036-8075

IS - 4980

ER -